Daniel F.
Bowen-Pope, PhD, Professor, Department of
Pathology
|
|
Predoc/ Postdoc |
Training period |
|
|
|
|
Ron Seifert |
Post |
84-86 |
PhD/84, U of WA |
Regulation of the PDGF/PDGF receptor system during aortic development |
Research Scientist, Dept of Pathology, U of Washington |
|
Rainer Gronwald |
Post |
86-89 |
MD/86, U of Heidelberg |
Cloning and regulation of PDGF receptor b-subunit |
Director, Renal Dialysis Center, Nurnberg Germany |
|
Penny Phillips |
Post |
88-89 |
PhD/88, U of WA |
Binding properties of PDGF receptor subunits |
Staff Scientist, Sandoz, New Jersey |
|
Gina Schatteman |
Post |
89-93 |
PhD/84, Johns Hopkins |
Expression and function of PDGFRa during murine development |
Associate Prof, Dept. of Exercise Science, University of Iowa |
|
Tom Barrett |
Post |
90-94 |
MD, PhD/77, 87, U of WA |
Regulation of expression and function of PDGF receptors |
Physician, Calif |
|
Karen Deyerle |
Post |
91-94 |
PhD/88, UC San Diego |
Use of mouse aggregation chimeras to evaluate PDGF receptor function in vivo |
Manager for Health Sciences, Office of Technology Transfer, UW |
|
David Maher |
Post |
92-95 |
PhD/92, UC San Diego |
Expression and function of vascular protein tyrosine kinases |
Patent Assoc Intellectual Property, Sugen, Inc. |
|
Christian Hugo |
Post |
95-96 |
MD/93, U of Erlangen-Nurnberg |
Discovery and characterization of a novel phosphatase upregulated during glomerular mesangial cell activation |
Assistant Prof, Dept of Medicine, Erlangen, Germany |
|
Charles Hart |
Pre |
84-87 |
PhD/87, U of WA |
PhD thesis defense 87:PDGF receptor |
Senior Director, Strategic Planning, ZymoGenetics, Seattle, WA |
|
James Kelly |
Pre |
86-91 |
PhD/91, U of WA |
“Studies of PDGF/receptor interaction” |
Staff scientist, ZymoGenetics, Seattle, WA |
|
Luis Borges |
Pre |
90-95 |
BA/85, U of Lisbon |
Cloning and characterization of vascular tyrosine phosphatases |
Staff Scientist, Immunex, Seattle WA |
|
Jeff Crosby |
Post |
95-98 |
PhD/95, U of Colorado |
Chimeric analysis of PDGFR function |
Staff Scientist, ISIS Pharmaceuticals, California |
|
Matthew Wright |
Post |
94-98 |
PhD/94, Northwestern U |
Cloning and characterization of vascular tyrosine phosphatases |
Staff Scientist/Group leader, Hoffmann-La Roche, Basel, Switzerland |
|
Ravi Ramachandran |
Post |
96-00 |
PhD/96, U of Houston |
Cloning and characterization of PTPases from vascular lesions |
Senior Research Scientist, CuraGen Corporation, New Jersey |
|
Friedemann Schaub |
Pre/Post |
96-present |
MD/96, U of Munich |
Regulation of vascular restenosis by manipulation of transgene expression |
Graduate student, PO1 HL 03174 |
|
Anush Oganesian |
Post |
97-01 |
PhD/88, Inst Moscow |
Function of mesangial phosphatase |
Research Scientist, Pathology, UW |
|
Bernard Buetow |
Pre/Post |
98-present |
DVM/89, U of Illinois |
Chimera analysis |
NIH HL03174 |
|
Monja Dishmon |
Pre |
01-present |
BS/1999, Arizona State U |
Regulation of PTPRQ |
Predoc, IMCBP training grant |
|
Carmen Booth |
Pre/Post |
00-present |
DVM/1992, UC Davis |
Chimera analysis |
Postdoc, CVP training grant |